Two lots of MAR-Amlodipine 5 mg tablets recalled as some bottles may contain the wrong drug

Product safety

Date

2026-02-07

Country

Canada

Product

MAR-Amlodipine 5 mg, DIN 02371715

Category

Drugs & medical

Source

Health Canada

Copied automatically from the Government of Canada. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

1. Check the product name, strength and lot number against the official notice.
2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the Government of Canada has the exact models, batch codes and remedy, and it takes priority.

Other drugs & medical recalls in Canada

1. 2026-02-09
2. CA
   Drugs & medicalType II

   TARO-CANDESARTAN: Affected lots were manufactured using an active ingredient that was out of specification for dissolution

   Product quality

   Health CanadaOfficial notice →
3. CA
   Drugs & medicalType III

   Cefazolin for Injection: Affected lots are packaged with the incorrect Linear barcode on inner and outer bag labels.

   Labelling

   Health CanadaOfficial notice →
4. CA
   Drugs & medicalType I

   MAR-AMLODIPINE: affected lots may contain tablet(s) of Midodrine 2.5mg tablets.

   Product safety

   Health CanadaOfficial notice →
5. 2026-02-06
6. CA
   Drugs & medicalType II

   UHI-3 High Flow Insufflation System - Insufflator

   Performance

   Health CanadaOfficial notice →
7. 2026-02-05
8. CA
   Drugs & medicalType II

   Centricity™ Universal Viewer Zero Footprint Client

   Performance

   Health CanadaOfficial notice →
9. CA
   Drugs & medicalType II

   DxC 700 AU and AU5800 Clinical Chemistry Analyzers

   Performance

   Health CanadaOfficial notice →